Towards the mode of action of the clinical stage all-D-enantiomeric peptide RD2 on Aβ42 aggregation

Zhang, Tao; Gering, Ian; Kutzsche, Janine; Nagel-Steger, Luitgard; Willbold, Dieter

doi:10.1021/acschemneuro.9b00458

Record: found
Abstract: not found
Article: not found

Towards the mode of action of the clinical stage all-D-enantiomeric peptide RD2 on Aβ42 aggregation

Author(s): Tao Zhang , Ian Gering , Janine Kutzsche , Luitgard Nagel-Steger , Dieter Willbold

Publication date Created: November 11 2019

Publication date (Electronic): November 11 2019

Journal: ACS Chemical Neuroscience

Publisher: American Chemical Society (ACS)

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: ACS Chemical Neuroscience

Abbreviated Title: ACS Chem. Neurosci.

Publisher: American Chemical Society (ACS)

ISSN (Print): 1948-7193

ISSN (Electronic): 1948-7193

Publication date Created: November 11 2019

Publication date (Electronic): November 11 2019

Article

DOI: 10.1021/acschemneuro.9b00458

PubMed ID: 31710458

SO-VID: 30a8973b-bc07-4c6f-a272-37ebfd10d45f

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by

Towards the mode of action of the clinical stage all-D-enantiomeric peptide RD2 on Aβ42 aggregation

Read this article at

Related collections

SDG 13: Climate Action

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 1,356

Cited by 6